Hong Kong-listed pharmaceutical outsourcing concept stocks continued to weaken during the session, with Joinn Laboratories (06127.HK) and Kanglong Pharmaceutical (03759.HK) both falling by more than 5%, Genscript Biotech (01548.HK) falling by nearly 5%, and Asymchem Laboratories (06821.HK) falling by more than 3%.